Effects of TGF-β2, BMP-4, and gremlin in the trabecular meshwork: Implications for glaucoma

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 3, 2007, Pages 1191-1200

  Wordinger, Robert J ^a   Fleenor, Debra L ^b   Hellberg, Peggy E ^b   Pang, Iok Hou ^a,b   Tovar, Tara O ^a   Zode, Gulab S ^a   Fuller, John A ^a   Clark, Abbot F ^a,b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; FIBRONECTIN; MESSENGER RNA; PROTEIN INHIBITOR; RECOMBINANT GREMLIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CKTSF1B1 PROTEIN, HUMAN; SIGNAL PEPTIDE; SMAD PROTEIN;

ANTERIOR EYE SEGMENT; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MICROARRAY ANALYSIS; MULTIGENE FAMILY; OPEN ANGLE GLAUCOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TISSUE PERFUSION; TRABECULAR MESHWORK; WESTERN BLOTTING; CELL CULTURE; DNA MICROARRAY; DRUG EFFECT; GENETICS; METABOLISM; ORGAN CULTURE TECHNIQUE; PHOSPHORYLATION;

BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; GLAUCOMA, OPEN-ANGLE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRAOCULAR PRESSURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD PROTEINS; TRABECULAR MESHWORK; TRANSFORMING GROWTH FACTOR BETA2;

EID: 34047268565     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0296     Document Type: Article

References (48)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
3. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
4. Rohen JW. Why is intraocular pressure elevated in chronic simple glaucoma? Ophthalmology. 1983;90:758-765.
5. Lutjen-Drecoll E, Rittig M, Rauterberg J, Jander R, Mollenhauer J. Immunomicroscopical study of type VI collagen in the trabecular meshwork of normal and glaucomatous eyes. Exp Eye Res. 1989;48:139-147.
6. Lütjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGFβ2 for the pathogenesis of the disease. Exp Eye Res. 2005;81:1-4.
7. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res. 1994;59:723-727.
8. Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol. 2001;239:109-113.
9. Picht G, Welge-Luessen U, Grehn F, Lütjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001;239:199-207.
10. Welge-Lussen U, May CA, Lütjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2. Invest Ophthalmol Vis Sci. 2000;41:2229-2238.
11. Gottanka J, Chan D, Eichhorn M, Lütjen-Drecoll E, Ethier CR. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci. 2004;45:153-158.
12. Fuchshofer R, Welge-Lussen U, Lütjen -Drecoll E. The effect of TGFb-2 on human trabecular meshwork extracellular proteolytic system. Exp Eye Res. 2003;77:757-765.
13. Wordinger RJ, Clark AF, Agarwal R, et al. Cultured human trabecular meshwork cells express functional growth factor receptors. Invest Ophthalmol Vis Sci. 1998;39:1575-1589.
14. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242:1528-1534.
15. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol. 2002;250:231-250.
16. Von Bubnoff A, Cho KW. Intracellular regulation in vertebrates: pathway or network? Dev Biol. 2001;239:1-14.
17. Hsu DR, Economides AN. The Xenopus dorsalizing factor gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell. 1998;1:673-683.
18. Topol LZ, Bardot B. Biosynthesis, post-translational modification and functional characterization of Drm/gremlin. J Biol Chem. 2000;275:8785-8793.
19. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocrince Revs. 2004;25:72-101.
20. Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark AF. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis. 2002;8:241-250.
21. Wilson K, McCartney MD, Miggans ST, Clark AF. Dexamethasone induced ultrastructural changes in cultured human trabecular meshwork cells. Curr Eye Res. 1993;12:783-793.
22. Steely HT, Browder SL, Julian MB, Miggans ST, Wilson KL, Clark AF. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1992;33:2242-2250.
23. Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M, Howe W. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-294.
24. Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci. 1995;36:478-489.
25. Clark AF, Steely HT, Dickerson JE Jr, et al. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci. 2001;42:1769-1780.
26. Wordinger RJ, Lambert W, Agarwal R, Talati M, Clark AF. Human trabecular meshwork cells secrete neurotrophins and express neurotrophin receptors (Trk). Invest Ophthalmol Vis Sci. 2000;41:3833-3841.
27. Pang I-H, Shade DL, Clark AF, Steely HT, DeSantis L. Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res. 1994;13:51-63.
28. Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, Clark AF. TFGb2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2005;47:226-234.
29. Johnson DH, Tschumper RC. Human trabecular meshwork organ culture: a new method. Invest Ophthalmol Vis Sci. 1987;28:945-953.
30. Clark AF, Brotchie D. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton. 2005;60:83-95.
31. Pang IH, McCartney MD, Steely HT, Clark AF. Human ocular perfusion organ culture: a versatile ex vivo model for glaucoma research. J Glaucoma. 2000;9:468-479.
32. Pang IH, Moll H, McLaughlin MA, et al. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate) . Exp Eye Res. 2001;73:815-825.
33. Pang IH, Fleenor DL, Hellberg PE, Stropki K, McCartney MD, Clark AF. Aqueous outflow-enhancing effect of tert-butylhydroquinone: involvement of AP-1 activation and MMP-3 expression. Invest Ophthalmol Vis Sci. 2003;44:3502-3510.
34. Zeisberg M, Hanai J-I, Sugimoto H, et al. BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003;9:964-968.
35. Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med. 2004;82:175-181.
36. Ochiai Y, Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol. 2002;46:249-253.
37. Dudley AT, Robertson EJ. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue effects in BMP-7 deficient embryos. Dev Dyn. 1997;208:349-362.
38. Liu J, Wilson S, Reh T. BMP receptor 1b is required for axon guidance and cell survival in the developing retina. Dev Biol. 2003;256:34-48.
39. Furuta Y, Hogan BL. BMP-4 is essential for lens induction in the mouse embryo. Genes Dev. 1998;3764-3775.
40. Luo G, Hofmann C, Bronkers AL, Sohocki M, Bradley A, Karsenty G. BMP-7 is an inducer of nephrogenesis and is also required for eye development and skeletal patterning. Genes Dev. 1995;9:2808-2820.
41. Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 1995;9:2795-2807.
42. Jena N, Martin-Seisdedos C, McCue P, Croce CM. BMP-7 null mutations in mice: developmental defects in skeleton, kidney and eye. Exp Cell Res. 1997;230:28-37.
43. Wawersik S, Purcell P, Rauchman M, Dudley AT, Robertson EJ. BMP-7 acts in murine lens placode development. Dev Biol. 1999;207:176-188.
44. Chang B, Smith RS, Peters M, et al. Haploinsufficient BMP-4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genetics. 2001;2:1-18.
45. Wang S, Hirschberg, R. Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem. 2004;279:23200-23206.
46. Izumi N, Mizuguchi S, Inagaki Y, et al. BMP-7 opposes TGFβ-1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. Am J Physiol. 2006;290:L120-L126.
47. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet. 2001;29:117-129.
48. Isasaki M, Iguchi M. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of the neunte outgrowth in PC-12 cells by bone morphogenetic protein-2. J Biol Chem. 1999;274:26503-26510.